NasdaqGS:IDXXMedical Equipment
A Look At IDEXX Laboratories (IDXX) Valuation After Strong Results And Positive 2026 Outlook
IDEXX Laboratories (IDXX) is back in the spotlight after reporting fourth quarter and full year 2025 results, with higher sales, net income, and earnings per share, along with new 2026 revenue and EPS guidance.
See our latest analysis for IDEXX Laboratories.
The fresh earnings and 2026 outlook arrive after a mixed stretch for the share price, with a 1-day share price return of 1.05% and 7-day share price return of 2.21%. These gains are offset by a 30-day share price return decline of 9.37%...